Founded in 1977, Jarrow is a leading independent formulator, manufacturer, and marketer of high-quality and scientifically supported probiotics, vitamins, minerals and supplements (“VMS”). The Company has a long heritage of producing innovative and efficacious formulations, having grown from a handful of products to hundreds of nutritional formulations, many of which were firsts for the dietary supplement industry. Jarrow’s goal to promote optimal health with high-quality, effective and affordable dietary supplements has cultivated an attractive, knowledgeable, loyal and global customer base.
New Mountain’s investment in Jarrow is the result of the firm’s long-standing sector initiatives in consumer health & wellness (including VMS specifically), life sciences and food ingredients, as previously reflected by investments including Avantor, NuSil, Topix, Gelest and Aceto. New Mountain first learned of Jarrow in May 2019 as the Company was a customer of Aceto, another Fund V portfolio company, and New Mountain was able to initiate a dialogue with Jarrow as the founders sought a value-added partner to support the Company in its next phase of growth. Given its deep sector knowledge, growth-focused perspective and track record working with founders, NMC was able to build a relationship with Jarrow’s founders and ultimately consummate a transaction under extended exclusivity outside a formal auction process.